Skip to main content

Advertisement

Log in

Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora

  • Original Paper
  • Published:
World Journal of Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

To investigate Lactobacillus acidophilus (L. acidophilus) and Bifidobacterium bifidum (B. bifidum) supplementation to triple therapy for Helicobacter pylori (H. pylori) eradication and dynamic changes in intestinal flora in children with H. pylori infection. One hundred H. pylori-infected children were randomly assigned to two groups: treatment group (n = 43), standard triple anti-H. pylori therapy plus probiotics of L. acidophilus and B. bifidum for 2 weeks followed by taking probiotics for another 4 weeks; control group (n = 45), standard triple anti-H. pylori therapy for 6 weeks. After 6-week treatment, 13C-urease breath test was performed and side effects were monitored during the observation period. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers was carried out for the analysis of human intestinal B. bifidum, L. acidophilus, and Escherichia coli (E. coli). As expected, treatment group could significantly enhance the H. pylori eradication rate (83.7 vs. 64.4 %, P < 0.05). B. bifidum, L. acidophilus, and E. coli showed no statistical difference before or after therapy in the treatment group. The number of B. bifidum and L. acidophilus was significantly decreased after 2-week treatment in the control group, but after 6-week treatment it significantly increased and nearly returned to the level before treatment. The number of E. coli increased significantly after 2-week treatment, while after 6-week treatment, it nearly decreased to the level before treatment. L. acidophilus and B. bifidum supplementation is effective for H. pylori eradication compared with triple therapy alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Ahmad K, Fatemeh F, Mehri N, Maryam S (2013) Probiotics for the treatment of pediatric helicobacter pylori infection: a randomized double blind clinical trial. Iran J Pediatr 23:79

    Google Scholar 

  • Bazzoli F, Zagari RM, Fossi S, Pozzato P, Roda A, Roda E (1993) Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 104:140

    Google Scholar 

  • Bell G, Powell K, Burridge S, Pallecaros A, Jones P, Gant P, Harrison G, Trowell J (1992) Experience with ‘triple’ anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 6:427–435

    Article  CAS  Google Scholar 

  • Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A (2000) A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 14:1625–1629

    Article  CAS  Google Scholar 

  • Chen Yun-hua, Wang Chun-lian, Xie Y (2007) Progress of research into the pathogenic mechanism of Helicobacter pylori and the preventive role of probiotics in H pylori infection. World Chinese Journal of Digestology 15:2690–2697

    CAS  Google Scholar 

  • Corthésy B, Gaskins HR, Mercenier A (2007) Cross-talk between probiotic bacteria and the host immune system. J nutr 137:781S–790S

    Google Scholar 

  • Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A (2002) Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97:2744–2749

    Article  Google Scholar 

  • Fortun-Lamothe L, Boullier S (2007) A review on the interactions between gut microflora and digestive mucosal immunity. Possible ways to improve the health of rabbits. Livestock Sci 107:1–18

    Article  Google Scholar 

  • Goldman CG, Barrado DA, Balcarce N, Rua EC, Oshiro M, Calcagno ML, Janjetic M, Fuda J, Weill R, Salgueiro MJ, Valencia ME, Zubillaga MB, Boccio JR (2006) Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children. Nutrition 22:984–988

    Article  Google Scholar 

  • Golledge CL, Riley TV (1995) Clostridium difficile-associated diarrhoea after doxycycline malaria prophylaxis. Lancet 345:1377–1378

    Article  CAS  Google Scholar 

  • Howden CW, Hunt RH (1998) Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol 93:2330–2338

    Article  CAS  Google Scholar 

  • Iakovenko EP, Grigor’ev PIa, Iakovenko AV, Agafonova NA, Prianishnikova AS, Sheregova EN, Vasil’ev IV, Komleva IuV, Oprishchenko IV, Anashkin VA (2006) Effects of probiotic bifiform on efficacy of Helicobacter pylori infection treatment. Ter Arkh 78:21–26

    CAS  Google Scholar 

  • Johannes GK, Arnoud HMV, JK. E (2006) Pathogenesis of Helicobacter pylori infection. Clin Mierobiol Rev 19:449-491

  • Lebeer S, Vanderleyden J, De Keersmaecker SC (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8:171–184

    Article  CAS  Google Scholar 

  • Lee JS, Paek NS, Kwon OS, Hahm KB (2010) Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling (SOCS) expression and signaling in Helicobacter pylori infection: a novel mechanism. J Gastroenterol Hepatol 25:194–202

    Article  CAS  Google Scholar 

  • Levy SB (1997) Antibiotic resistance: an ecological imbalance. Antibiotic resistance: origins, evolution, selection and spread 207:1–14

    CAS  Google Scholar 

  • Lou Jin-gan, Chen J (2005) Change of intestinal microecosystem after Helicobacter pylori triple therapy in childern. Chinese Journal of microecology 17:124–125

    Google Scholar 

  • Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. GASTROENTEROLOGY-BALTIMORE THEN PHILADELPHIA- 121:580–591

    CAS  Google Scholar 

  • Marshall B, Warren JR, Blincow E, Phillips M, Goodwin CS, Murray R, Blackbourn S, Waters T, Sanderson C (1988) Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. The Lancet 332:1437–1442

    Article  Google Scholar 

  • Mourad-Baars P, Hussey S (2010) Helicobacter pylori infection and childhood. Helicobacter 15:53–59

    Article  Google Scholar 

  • Mrda Z, Zivanović M, Rasić J, Gajin S, Somer L, Trbojević S, Majoros J (1998) Therapy of Helicobacter pylori infection using Lactobacillus acidophilus. Med Pregl 51:343–345

    CAS  Google Scholar 

  • Mullié C, Odou MF, Singer E, Romond MB, Izard D (2003) Multiplex PCR using 16S rRNA gene-targeted primers for the identification of bifidobacteria from human origin. FEMS Microbiol Lett 222:129–136

    Article  Google Scholar 

  • Sabbi T (2011) Short review about Helicobacter pylori infection in pediatric age: epidemiological and clinical findings, diagnosis, therapy and role of probiotics. Pediatr Med Chir 33:221–226

    CAS  Google Scholar 

  • Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A (2004) In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl Environ Microbiol 70:518–526

    Article  CAS  Google Scholar 

  • Song YL, Kato N, Liu CX, Matsumiya Y, Kato H, Watanabe K (2000) Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group-and species-specific primers derived from the 16S–23S rRNA intergenic spacer region and its flanking 23S rRNA. FEMS Microbiol Lett 187:167–173

    CAS  Google Scholar 

  • Szajewska H, Horvath A, Piwowarczyk A (2010) Meta-analysis: the effects of Sacharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 32:1069–1079

    Article  CAS  Google Scholar 

  • Tam YH, Yeung CK, Lee KH, Sihoe JD, Chan KW, Cheung ST, Mou JW (2008) A population-based study of Helicobacter pylori infection in Chinese children resident in Hong Kong: prevalence and potential risk factors. Helicobacter 13:219–224

    Article  Google Scholar 

  • Teare JP, Booth J, Brown JL, Martin J, Thomas HJ (1995) Pseudomembranous colitis following clarithromycin therapy. Eur J Gastroenterol Hepatol 7:275–277

    CAS  Google Scholar 

  • The Editorial Board Chinese Journal of Pediatrics (2000) The subspeciahy group of infectious diseases and gastroenterology, association. SoPCM: the recommendations of chronic gastritis and peptic ulcer in children. Chin J Pediatr 38:201–202

    Google Scholar 

  • Tolone S, Pellino V, Vitaliti G, Tolone C (2012) Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone. Ital J Pediatr 38:1–5

    Article  Google Scholar 

  • Tong Jin-lu, Ran Zhi-hua, Shen Jun, Xiao S-d (2007) Effect of probiotics supplementation on standard triple therapy for helicobacter pylori eradication: a systematic review. Chin J Gastro 12:662–666

    Google Scholar 

  • Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K (2004) Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70:1176–1181

    Article  CAS  Google Scholar 

  • van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ (1996) Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1:6

    Article  Google Scholar 

  • Van der Waaij D (1971) Berghuis-de Vries J, Lekkerkerk-Van der Wees J: colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg 69:405–411

    Article  Google Scholar 

  • Weisburg WG, Barns SM, Pelletier DA, Lane DJ (1991) 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 173:697–703

    CAS  Google Scholar 

  • Yang YJ, Chuang CC, Yang HB, Lu CC, Sheu BS (2012) Lactobacillus acidophilus ameliorates H. pylori-induced gastric inflammation by inactivating the Smad7 and NFκB pathways. BMC Microbiol 12:38

    Article  CAS  Google Scholar 

  • Zhu Di-ling, YANG Hui-ming, J-r Li (2011) Meta-analysis: combination of probiotics with triple therapy for Helicobacter pylori eradication in children J. Clin Pediatr 29:278–282

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ying Huang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Yh., Huang, Y. Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora. World J Microbiol Biotechnol 30, 847–853 (2014). https://doi.org/10.1007/s11274-013-1490-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11274-013-1490-2

Keywords

Navigation